Assessing the Neurological Outcomes After Atrial Fibrillation Ablation for Rhythm Control
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorKansas City Heart Rhythm Research Foundation
About this trial
A prospective, non-blinded, multi-center study to assess the impact of early Catheter Ablation (CA) in patients with a new diagnosis of Atrial Fibrillation(AF) at the time of stroke. 100 patients will be enrolled.
Eligibility criteria
Qualifiers
Ages >18 and able to provide consent.
Presenting with an acute stroke and new-onset AF
Modified RANKIN score (mRS) < 6
Must be able to undergo some form of cardiac monitoring [implantable loop recorder (ILR), electrocardiogram (ECG), Holter monitor] to quantify AF burden
Disqualifiers
Patients < 18 years of age
Unable to provide consent, including mRS = 6.
Not able to read and write at an 8th-grade level [to complete AFEQT and EQ-5D surveys]
Positive B-hCG
Trial design
Treatments tested in this trial
- Catheter Ablation
- Market-approved AVNB, OAC and AAD
Treatment groups
100 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov